QNRX logo
QNRX NASDAQ IL

Quoin Pharmaceuticals, Ltd. - American Depositary Shares

Healthcare · Biotechnology Website · IPO Nov 1989
$7.02
▲ +$0.96 (+15.84%)
Vol 59K
2
Quality Score
fail
Mkt Cap
$8.5M
ROE
-210.5%
D/E
102.84
Beta
1.70
52W
$5–$42

Wall Street Consensus

8 analysts · Apr 2026
2
Strong Buy
5
Buy
1
Hold
0
Sell
0
Strong Sell
87.5%
Buy Rating

Price Chart

Similar Stocks

NRSN
Neurosense Therapeutics Ltd
$22.8M
PLRZ
Polyrizon Ltd
$13.5M
CMMB
Chemomab Therapeutics Ltd
$10.1M
CLGN
Collplant Biotechnologies Ltd
$17.8M
EVGN
Evogene Ltd
$9.6M
SLXN
Silexion Therapeutics Corp
$6.0M
URGN
Urogen Pharma Ltd
$1.1B

Earnings

Beat rate: 60.0%
Next Report May 11, 2026
EPS Estimate: $-1.88
Quarter EPS Est EPS Act Surprise
Mar 2026 $-1.88 — —
Dec 2025 $-3.40 $-1.50 +$1.90
Sep 2025 $-5.08 $-6.71 $-1.63
Jun 2025 $-7.56 $-6.28 +$1.28

Fundamentals Trend

Metric 2025-06-30 2025-09-02 2025-10-02 2025-11-03 2025-12-03 2026-01-02
ROE (TTM) -210.5% -149.0% -210.5% -210.5% -210.5% -210.5%
P/E (TTM) — — — — — —
Net Margin — — — — — —
Gross Margin — — — — — —
D/E Ratio 102.84 46.81 102.84 102.84 102.84 102.84
Current Ratio 1.95 2.57 1.95 1.95 1.95 1.04

Key Ratios

ROA (TTM)
-125.2%
P/B
0.6
EPS (TTM)
$-19.85
CF/Share
$0.00
52W High
$41.80
52W Low
$5.01
$5.01 52-Week Range $41.80

How does QNRX compare to Biotechnology peers?

Peer group: Micro-cap Biotechnology (All) · 528 companies

QNRX AAPG ABEO ABOS ABP

QNRX valuation vs Biotechnology peers

P/E ratio
—
▼ 0% below peers (18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
—
▼ 0% below peers (12.9)
vs Peers
vs Industry
Overvalued
P/B ratio
0.6
▼ 76% below peers (2.5)
vs Peers
vs Industry
Undervalued
Div yield
—
▼ 0% below peers (0.0%)
vs Peers
vs Industry
Low yield

QNRX profitability vs Biotechnology peers

ROE
-210.5%
▼ 213% below peers (-67.3%)
vs Peers
vs Industry
Weak
Net margin
—
▼ 0% below peers (-286.8%)
vs Peers
vs Industry
Top tier
Gross margin
—
▼ 0% below peers (78.6%)
vs Peers
vs Industry
In line
ROA
-125.2%
▼ 168% below peers (-46.7%)
vs Peers
vs Industry
Weak

QNRX financial health vs Biotechnology peers

D/E ratio
102.8
▼ 0% below peers (0.0)
vs Peers
vs Industry
High debt
Current ratio
1.0
▼ 76% below peers (4.4)
vs Peers
vs Industry
Low liquidity
Beta
1.7
▲ 75% above peers (1.0)
vs Peers
vs Industry
More volatile

QNRX fundamentals radar

QNRX Peer median Industry

QNRX profitability vs leverage

Bubble size = market cap · X = net margin · Y = D/E ratio

QNRX vs peers: key metrics

Latest News

No related news yet